Comparative clinical study of alilocumab (Praluent) and evorocumab (Repatha) for dyslipidemia
Not Applicable
- Conditions
- Dyslipidemia using evolocumab
- Registration Number
- JPRN-UMIN000034592
- Lead Sponsor
- Sekino Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who were deemed not appropriate to participate in this study by doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method